DT-EQUIPMENT
16.2.2021 07:02:05 CET | Business Wire | Press release
DT Equipment ehf. (DTE) (www.dtequipment.com ), a leader in real-time intelligence from liquid metals and developer of next-generation analytics for metals production and processing, is pleased to announce the appointment of Mr. Diego Areces as Chief Commercial Officer (CCO). His hire marks the latest in a series of appointments designed to further strengthen the DTE executive team and ensure that the company has the strategic, commercial and technical capabilities required for the next stage of its growth.
Commenting on the new appointment, Karl Matthiasson, CEO of DTE said, “I am very pleased to welcome Diego to our expanding executive team. His vast industry knowledge and extensive commercial experience will be indispensable, and we are delighted to have him on board as we continue the next stage of our journey.”
Mr. Areces who has 25 years’ experience in the industrial automation field, joins DTE to lead its commercial activities after a long tenure at Schneider Electric, where he held the position of Industrial Automation Networks Leader, Mining, Minerals, and Metals President and Process Automation North Asia Hub Leader, responsible for driving growth, transformation, and innovation. He will focus on bringing DTE’s breakthrough innovations in the metals analytics field to market and developing strategic relationships with customers and significant stakeholders.
“I am thrilled to join DTE, a great team of talented professionals on its way to transform a whole industry thanks to its breakthrough innovation", added Mr. Areces, “It is clear from my decades of working in the metals processing field that DTE’s real-time analytics and intelligence capabilities represent a significant breakthrough which offers a genuine opportunity to transform the way producers operate. I am focused on maximizing growth, value, sustainability, safety, and efficiency for all stakeholders, developing strategic relationships, and deploying business-driven technology and innovation; I look forward to an exciting new phase where there are no limits to what we can accomplish.
Mr. Areces is one of the early precursors of Industry 4.0, leading the deployment of internet technologies in industrial devices during the early 2000s. He has been a safety and sustainability champion and a significant contributor to the digital transformation of global industrial customers.
Mr. Areces is a founding member of modbus.org, was a marketing chair of the Interface for Distributed Automation (IDA) organization and a member of the Development Partner Institute for Mining. He holds an MS in Electronic Engineering from the University of Buenos Aires, Argentina, and a CSS in Administration and Management from Harvard University, US.
Find out more about DTE’s real-time liquid metals intelligence solutions at www.dtequipment.com
###
About DT Equipment
DTE, based in Reykjavik, Iceland, is a leading innovator in the field of real-time intelligence from liquid metals, helping customers to maximize value, efficiency, safety and sustainability. DTE’s vision is to transform metals production and processing with next-generation sensors and analytics, driving digital transformation of the metals industry towards Industry 4.0, while contributing to the 1.5-degree challenge.
DTE’s solution range combines first-in-industry LP-LIBS™ (Liquid-Phase Laser-Induced Breakdown Spectroscopy) elemental analysis with a powerful machine learning cloud platform, delivering valuable intelligence and predictive insights from liquid metals across the entire value chain.
For more information, please visit www.dtequipment.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210215005203/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom